基于网络药理学、分子对接和动物实验探讨锦红片治疗外科炎性急腹症的作用机制OA
Exploration of mechanism of Jinhong tablets in the treatment of surgical acute abdomen based on network-pharmacology,molecular docking,and animal experiment
目的 采用网络药理学方法、分子对接手段和动物实验验证,分析锦红片治疗外科炎性急腹症的作用机制.方法 通过中药系统药理数据库和分析平台、中国科学院上海有机化学研究所中药与化学成分数据库、TCM-bank数据库等检索锦红片化学成分信息并进行活性成分筛选,在Uniprot、DrugBank、String、TCMSP等数据库进行靶点预测,应用Cytoscape 3.8.2软件构建成分-靶点网络;在Genecards数据库以"acute abdomen"为关键词检索获取疾病靶点;构建韦恩图得到锦红片治疗外科炎性急腹症的潜在作用靶点;应用Cytoscape 3.8.2软件进行锦红片活性成分-作用靶点-炎性急腹症疾病PPI网络构建、Mcode模块聚类构建筛选关键靶点;并进行基因本体(GO)功能注释和京都基因与基因组百科全书(KEGG)信号通路富集分析;构建锦红片中药-成分-靶点-通路网络.使用Cb-Dock2在线工具及Pymol软件等对山奈酚、泽兰素等有效成分与待验证靶点进行分子对接及可视化展示.然后,采用LPS诱导急性胆道感染大鼠进行验证.结果 网络药理学方法构建的锦红片中药-成分-靶点-通路网络包括13种活性成分(山奈酚、芦荟大黄素等),对应25个潜在靶点[PTGS2、蛋白激酶Bα(AKT1)等]以及10条信号通路(癌症通路、TNF信号通路、MAPK信号通路、癌症中的蛋白聚糖等).分子对接结果显示山奈酚、泽兰素、芦荟大黄素等6种活性成分与AKT1、诱导型一氧化氮合酶(NOS2)等靶点具有良好结合力,可视化过程展示8种结合状态.动物实验结果表明锦红片能够降低LPS诱导急性胆道感染大鼠胆管组织中AKT1、NOS2的表达,降低血清中MDA含量,提高血清中GSH含量,提升SOD活力.结论 本研究从网络药理学、分子对接、动物实验等多维度证明中药复方锦红片以"多成分、多靶点、多通路"的方式,通过山奈酚、泽兰素、芦荟大黄素等有效成分调节AKT1、NOS2,影响血清中SOD、GSH、MDA水平,发挥治疗外科炎性急腹症的作用.
Objective To analyze the the mechanism of action of Jinhong tablets in treating surgical inflammatory acute abdomen by network-pharmacology methods,molecular docking techniques and animal experiments verification.Methods The chemical constituents of Jinhong tablets were retrieved and active components were screened through traditional Chinese medicine systems pharmacology database and analysis platform(TCMSP),traditional Chinese medicine and chemical compo-sition database in Shanghai institute of organic chemistry,and TCMbank database,etc;the disease targets were retrieved by searching the Genecards database with the keyword"acute abdomen".Venn diagram was constructed to identify potential tar-gets for the treatment of surgical inflammatory acute abdomen with Jinhong tablets;and Cytoscape 3.8.2 software was used to construct a PPI network and Mcode module clustering for screening key targets in the active ingredients-action targets-inflam-matory acute abdomen disease of Jinhong tablets.Cb-Dock2 online tools and Pymol software were used to perform molecular docking and visualization display of effective ingredients such as kaempferol and puerarin with the target to be validated.Then,LPS was used to induce acute biliary tract infection in rats for validation.Results The network pharmacology meth-odology established for Jinhong tablets revealed a TCM-component-target-pathway network comprised 13 active components(including kaempferol,aloe-emodin,etc.),corresponding to 25 potential targets(PTGS2,AKT1,etc.)and 10 KEGG pathways(cancer pathway,TNF signaling pathway,MAPK signaling pathway,proteoglycans in cancer,etc.).Molecular docking results demonstrated strong binding affinity between 6 bioactive components(including kaempferol,euparin and aloe-emodin)had good binding affinity with targets such as AKT1 and inducible nitric oxide synthase(NOS2),and the visu-alization process displayed 8 binding states.Animal studies indicated that Jinhong tablets could reduce AKT1 and NOS2 expression in bile duct tissues of LPS-induced acute cholangitis rats,decrease serum malondialdehyde(MDA)levels,ele-vate serum glutathione(GSH)concentrations,and enhance superoxide dismutase(SOD)activity.Conclusion This study demonstrates from multiple dimensions such as network-pharmacology,molecular docking,and animal experiments that the traditional Chinese medicine compound Jinhong tablets,in a"multi-component,multi-target,and multi-pathway"manner,regulate AKT1 and NOS2 through effective components such as kaempferol,puerarin,and aloe-emodin in a"multi-compo-nent,multi-target,and multi pathway"manner,thereby affecting serum levels of SOD,GSH,and MDA,and exerting a therapeutic effect on surgical inflammatory acute abdomen.
李廷;马恩伟;周伟科;余奎;张静喆;顾宏刚
上海市金山区中西医结合医院普外科,上海 201501上海中医药大学附属龙华医院普外科,上海 200032上海市金山区中西医结合医院普外科,上海 201501上海中医药大学附属龙华医院浦东分院外科,上海 200126上海中医药大学附属龙华医院普外科,上海 200032上海中医药大学附属龙华医院普外科,上海 200032
医药卫生
锦红片网络药理学外科炎性急腹症分子对接蛋白激酶Bα诱导型一氧化氮合酶
Jinhong tabletsnetwork pharmacologysurgical acute abdomenmolecular dockingAKT1NOS2
《右江医学》 2026 (1)
7-18,12
国家自然科学基金青年科学基金项目(82004372)上海市金山区卫生健康系统科研课题中医项目(JSKJ-KTZY-2019-04)上海市金山区卫生健康系统第四周期"优秀青年人才"培养计划(JSYQ201912)上海市金山区卫生健康系统科研课题青年项目(JSKJ-KTYQ-2019-12)
评论